ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid ImagingAnders Sundin, Andreas Kjær, Eric P. Krenning et al.|Neuroendocrinology|2017Cited by 495
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine TumoursÉric Raymond, Nicola Fazio, Matthew H. Kulke et al.|Neuroendocrinology|2018Cited by 55
Pharmacogenomic Analyses of Sunitinib In Patients With Pancreatic Neuroendocrine TumorsNicola Fazio, Éric Raymond|Future Oncology|2019Cited by 13
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)Jaume Capdevila, Alice Durand, Virginia Pubul et al.|BMC Cancer|2025Cited by 7
Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)Jaume Capdevila, Alice Durand, Virginia Pubul et al.|BMC Cancer|2026Cited by 0